K. Strebhardt
Molecular Biology · 2006–2010
A researcher in the Science corpus: 3 papers; trusts 17 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 53 citations into it; #6,583 of 17,773 by trust here, #13,891 by citations
- Cell Biology — 32 citations into it; #496 of 2,073 by trust here, #1,574 by citations
- Oncology — 32 citations into it; #342 of 1,698 by trust here, #1,023 by citations
- Cancer Research — 10 citations into it
- Radiology, Nuclear Medicine and Imaging — 5 citations into it; #2,894 of 3,265 by trust here, #1,970 by citations
Whom K. Strebhardt trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- K. Frese
- J. Ludwig
- A. Ullrich
- Ji Luo
- D. Tuveson
- John N. Weinstein
- A. Esquela-Kerscher
- Tony Gutschner
- N. Keen
- Robert Habedanck
Who trusts K. Strebhardt overall
- Ji Luo
- P. Muller
- Paul Polakis
- Marcos Malumbres
- N. Solimini
- Stephen J. Elledge
- S. Lens
- Pranali P. Deshpande
Papers from K. Strebhardt's perspective
Ordered by how strongly the researchers K. Strebhardt trusts endorse each paper. Same corpus, a different order for every researcher.
- Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates (Science)
- The Protein Kinase Complement of the Human Genome (Science)
- Assembly of Cell Regulatory Systems Through Protein Interaction Domains (Science)
- Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
- Targeting polo-like kinase 1 for cancer therapy (Nature Reviews. Cancer)
- Cancer genes and the pathways they control (Nature Medicine)
- Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. (Science)
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
- The hallmarks of cancer (RNA Biology)
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
Their papers
- Targeting polo-like kinase 1 for cancer therapy (2006) — 858 citations
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy (2010) — 667 citations
- Paul Ehrlich's magic bullet concept: 100 years of progress (2008) — 1,327 citations